The US Food and Drug Administration (FDA) is committed to helping facilitate American patients’ access to lower-cost generic medicines by taking steps to enhance and streamline the development and ...

The US FDA Commissioner Scott Gottlieb announced new steps aimed at speeding up the process of reviewing generic drug marketing application and boosting competition. In a statement, the FDA regulator ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...